Isabelle Ducellier takes over as Managing Director of BioGaia
As BioGaia announced June 20, 2018, Isabelle Ducellier has been appointed new Managing Director of BioGaia. Now she takes up her position.
Isabelle Ducellier’s latest position was as General Secretary at the Swedish Childhood Cancer Fund. Previously, she has held a number of senior international positions within the Pernod Ricard Group for 20 years, latest as CEO of Pernod Ricard Sweden.
"I am pleased to finally be here and am starting to familiarize myself with the business. I look forward to working in the fast-growing probiotics market, in a company with a unique combination of leading-edge research and a strong brand. Moreover, I got a great start – BioGaia recently won the category “annual reports listed companies B2C” in the prestigious Swedish Publishing Prize,” says Isabelle Ducellier, Managing Director of BioGaia.
Latest press releases from BioGaia
10 / 24 / 2018 BioGaia AB Interim management statement 1 January – 30 September 2018
10 / 08 / 2018 MetaboGen reaches development goal – first product ready for safety study
09 / 17 / 2018 bWellness launches BioGaia Protectis tablets in Australia
For additional information please contact
Isabelle Ducellier, Managing Director, telephone: +46 8 555 293 00
BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are sold through local distribution partners in around 100 countries worldwide. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. www.biogaia.com